ACE and kidney disorder: For the risk of progression of renal disease (composite of ESRD, doubling of serum creatinine, and all-cause mortality), no significant differences were detected between ACE inhibitor and any of the remaining therapies, such as ARB or the combination of ACE inhibitor plus ARB.